Article Text

Download PDFPDF
MHRA: confusion over drug names

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Recent examples of medication errors arising from confusion between drug names (generic or brand) that look or sound similar have been highlighted by the Medicines and Healthcare products Regulatory Agency (MHRA).1 In 2010 and 2013, the MHRA issued safety alerts to remind healthcare professionals of the risks associated with confusion over drug names.2,3 The latest alert provides another reminder to …

View Full Text